Report Detail
Global (United States, European Union and China) Klebsiella Pneumoniae Infection Drug Market Research Report 2019-2025
- RnM3368543 |
- 14 July, 2020 |
- Global |
- 154 Pages |
- QYResearch |
- Pharma & Healthcare
Klebsiella Pneumoniae Infection Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Klebsiella Pneumoniae Infection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Klebsiella Pneumoniae Infection Drug market is segmented into
ATI-1503
CA-824
CC-1807
Cefiderocol
Debio-1454
EBX-004
Others
Segment by Application, the Klebsiella Pneumoniae Infection Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Klebsiella Pneumoniae Infection Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Klebsiella Pneumoniae Infection Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Klebsiella Pneumoniae Infection Drug Market Share Analysis
Klebsiella Pneumoniae Infection Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Klebsiella Pneumoniae Infection Drug business, the date to enter into the Klebsiella Pneumoniae Infection Drug market, Klebsiella Pneumoniae Infection Drug product introduction, recent developments, etc.
The major vendors covered:
Acies Bio doo
Appili Therapeutics
Debiopharm International SA
Evaxion Biotech ApS
F. Hoffmann-La Roche Ltd
FOB Synthesis Inc
ImmunoClin Corp
Innovation Pharmaceuticals Inc
Kyorin Pharmaceutical Co Ltd
Melinta Therapeutics Inc
Nosopharm SAS
Peptilogics Inc
Pfizer Inc
Phico Therapeutics Ltd
Sarepta Therapeutics Inc
Shionogi & Co Ltd
Syntiron LLC
Tetraphase Pharmaceuticals Inc
1 Study Coverage
- 1.1 Klebsiella Pneumoniae Infection Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Klebsiella Pneumoniae Infection Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Klebsiella Pneumoniae Infection Drug Market Size Growth Rate by Type
- 1.4.2 ATI-1503
- 1.4.3 CA-824
- 1.4.4 CC-1807
- 1.4.5 Cefiderocol
- 1.4.6 Debio-1454
- 1.4.7 EBX-004
- 1.4.8 Others
- 1.5 Market by Application
- 1.5.1 Global Klebsiella Pneumoniae Infection Drug Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Klebsiella Pneumoniae Infection Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Klebsiella Pneumoniae Infection Drug Revenue 2015-2026
- 2.1.2 Global Klebsiella Pneumoniae Infection Drug Sales 2015-2026
- 2.2 Global Klebsiella Pneumoniae Infection Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Klebsiella Pneumoniae Infection Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Klebsiella Pneumoniae Infection Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Klebsiella Pneumoniae Infection Drug Competitor Landscape by Players
- 3.1 Klebsiella Pneumoniae Infection Drug Sales by Manufacturers
- 3.1.1 Klebsiella Pneumoniae Infection Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Klebsiella Pneumoniae Infection Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Klebsiella Pneumoniae Infection Drug Revenue by Manufacturers
- 3.2.1 Klebsiella Pneumoniae Infection Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Klebsiella Pneumoniae Infection Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Klebsiella Pneumoniae Infection Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Klebsiella Pneumoniae Infection Drug Revenue in 2019
- 3.2.5 Global Klebsiella Pneumoniae Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Klebsiella Pneumoniae Infection Drug Price by Manufacturers
- 3.4 Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Klebsiella Pneumoniae Infection Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Klebsiella Pneumoniae Infection Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Klebsiella Pneumoniae Infection Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Klebsiella Pneumoniae Infection Drug Market Size by Type (2015-2020)
- 4.1.1 Global Klebsiella Pneumoniae Infection Drug Sales by Type (2015-2020)
- 4.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Type (2015-2020)
- 4.1.3 Klebsiella Pneumoniae Infection Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Klebsiella Pneumoniae Infection Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Klebsiella Pneumoniae Infection Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Klebsiella Pneumoniae Infection Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Klebsiella Pneumoniae Infection Drug Market Size by Application (2015-2020)
- 5.1.1 Global Klebsiella Pneumoniae Infection Drug Sales by Application (2015-2020)
- 5.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Application (2015-2020)
- 5.1.3 Klebsiella Pneumoniae Infection Drug Price by Application (2015-2020)
- 5.2 Klebsiella Pneumoniae Infection Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Klebsiella Pneumoniae Infection Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Klebsiella Pneumoniae Infection Drug by Country
- 6.1.1 North America Klebsiella Pneumoniae Infection Drug Sales by Country
- 6.1.2 North America Klebsiella Pneumoniae Infection Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Type
- 6.3 North America Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Klebsiella Pneumoniae Infection Drug by Country
- 7.1.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Country
- 7.1.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Type
- 7.3 Europe Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Klebsiella Pneumoniae Infection Drug by Region
- 8.1.1 Asia Pacific Klebsiella Pneumoniae Infection Drug Sales by Region
- 8.1.2 Asia Pacific Klebsiella Pneumoniae Infection Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Klebsiella Pneumoniae Infection Drug by Country
- 9.1.1 Latin America Klebsiella Pneumoniae Infection Drug Sales by Country
- 9.1.2 Latin America Klebsiella Pneumoniae Infection Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Type
- 9.3 Central & South America Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug by Country
- 10.1.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Country
- 10.1.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Klebsiella Pneumoniae Infection Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Acies Bio doo
- 11.1.1 Acies Bio doo Corporation Information
- 11.1.2 Acies Bio doo Description and Business Overview
- 11.1.3 Acies Bio doo Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Acies Bio doo Klebsiella Pneumoniae Infection Drug Products Offered
- 11.1.5 Acies Bio doo Related Developments
- 11.2 Appili Therapeutics
- 11.2.1 Appili Therapeutics Corporation Information
- 11.2.2 Appili Therapeutics Description and Business Overview
- 11.2.3 Appili Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Products Offered
- 11.2.5 Appili Therapeutics Related Developments
- 11.3 Debiopharm International SA
- 11.3.1 Debiopharm International SA Corporation Information
- 11.3.2 Debiopharm International SA Description and Business Overview
- 11.3.3 Debiopharm International SA Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Products Offered
- 11.3.5 Debiopharm International SA Related Developments
- 11.4 Evaxion Biotech ApS
- 11.4.1 Evaxion Biotech ApS Corporation Information
- 11.4.2 Evaxion Biotech ApS Description and Business Overview
- 11.4.3 Evaxion Biotech ApS Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Products Offered
- 11.4.5 Evaxion Biotech ApS Related Developments
- 11.5 F. Hoffmann-La Roche Ltd
- 11.5.1 F. Hoffmann-La Roche Ltd Corporation Information
- 11.5.2 F. Hoffmann-La Roche Ltd Description and Business Overview
- 11.5.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Products Offered
- 11.5.5 F. Hoffmann-La Roche Ltd Related Developments
- 11.6 FOB Synthesis Inc
- 11.6.1 FOB Synthesis Inc Corporation Information
- 11.6.2 FOB Synthesis Inc Description and Business Overview
- 11.6.3 FOB Synthesis Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Products Offered
- 11.6.5 FOB Synthesis Inc Related Developments
- 11.7 ImmunoClin Corp
- 11.7.1 ImmunoClin Corp Corporation Information
- 11.7.2 ImmunoClin Corp Description and Business Overview
- 11.7.3 ImmunoClin Corp Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Products Offered
- 11.7.5 ImmunoClin Corp Related Developments
- 11.8 Innovation Pharmaceuticals Inc
- 11.8.1 Innovation Pharmaceuticals Inc Corporation Information
- 11.8.2 Innovation Pharmaceuticals Inc Description and Business Overview
- 11.8.3 Innovation Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Products Offered
- 11.8.5 Innovation Pharmaceuticals Inc Related Developments
- 11.9 Kyorin Pharmaceutical Co Ltd
- 11.9.1 Kyorin Pharmaceutical Co Ltd Corporation Information
- 11.9.2 Kyorin Pharmaceutical Co Ltd Description and Business Overview
- 11.9.3 Kyorin Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Products Offered
- 11.9.5 Kyorin Pharmaceutical Co Ltd Related Developments
- 11.10 Melinta Therapeutics Inc
- 11.10.1 Melinta Therapeutics Inc Corporation Information
- 11.10.2 Melinta Therapeutics Inc Description and Business Overview
- 11.10.3 Melinta Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Products Offered
- 11.10.5 Melinta Therapeutics Inc Related Developments
- 11.1 Acies Bio doo
- 11.1.1 Acies Bio doo Corporation Information
- 11.1.2 Acies Bio doo Description and Business Overview
- 11.1.3 Acies Bio doo Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Acies Bio doo Klebsiella Pneumoniae Infection Drug Products Offered
- 11.1.5 Acies Bio doo Related Developments
- 11.12 Peptilogics Inc
- 11.12.1 Peptilogics Inc Corporation Information
- 11.12.2 Peptilogics Inc Description and Business Overview
- 11.12.3 Peptilogics Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Peptilogics Inc Products Offered
- 11.12.5 Peptilogics Inc Related Developments
- 11.13 Pfizer Inc
- 11.13.1 Pfizer Inc Corporation Information
- 11.13.2 Pfizer Inc Description and Business Overview
- 11.13.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Pfizer Inc Products Offered
- 11.13.5 Pfizer Inc Related Developments
- 11.14 Phico Therapeutics Ltd
- 11.14.1 Phico Therapeutics Ltd Corporation Information
- 11.14.2 Phico Therapeutics Ltd Description and Business Overview
- 11.14.3 Phico Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Phico Therapeutics Ltd Products Offered
- 11.14.5 Phico Therapeutics Ltd Related Developments
- 11.15 Sarepta Therapeutics Inc
- 11.15.1 Sarepta Therapeutics Inc Corporation Information
- 11.15.2 Sarepta Therapeutics Inc Description and Business Overview
- 11.15.3 Sarepta Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Sarepta Therapeutics Inc Products Offered
- 11.15.5 Sarepta Therapeutics Inc Related Developments
- 11.16 Shionogi & Co Ltd
- 11.16.1 Shionogi & Co Ltd Corporation Information
- 11.16.2 Shionogi & Co Ltd Description and Business Overview
- 11.16.3 Shionogi & Co Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Shionogi & Co Ltd Products Offered
- 11.16.5 Shionogi & Co Ltd Related Developments
- 11.17 Syntiron LLC
- 11.17.1 Syntiron LLC Corporation Information
- 11.17.2 Syntiron LLC Description and Business Overview
- 11.17.3 Syntiron LLC Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Syntiron LLC Products Offered
- 11.17.5 Syntiron LLC Related Developments
- 11.18 Tetraphase Pharmaceuticals Inc
- 11.18.1 Tetraphase Pharmaceuticals Inc Corporation Information
- 11.18.2 Tetraphase Pharmaceuticals Inc Description and Business Overview
- 11.18.3 Tetraphase Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Tetraphase Pharmaceuticals Inc Products Offered
- 11.18.5 Tetraphase Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Klebsiella Pneumoniae Infection Drug Market Estimates and Projections by Region
- 12.1.1 Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Klebsiella Pneumoniae Infection Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Klebsiella Pneumoniae Infection Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Klebsiella Pneumoniae Infection Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Klebsiella Pneumoniae Infection Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Klebsiella Pneumoniae Infection Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Klebsiella Pneumoniae Infection Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Klebsiella Pneumoniae Infection Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Klebsiella Pneumoniae Infection Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Klebsiella Pneumoniae Infection Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Klebsiella Pneumoniae Infection Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Klebsiella Pneumoniae Infection Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Klebsiella Pneumoniae Infection Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Klebsiella Pneumoniae Infection Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Klebsiella Pneumoniae Infection Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Klebsiella Pneumoniae Infection Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Klebsiella Pneumoniae Infection Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Klebsiella Pneumoniae Infection Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Klebsiella Pneumoniae Infection Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Klebsiella Pneumoniae Infection Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Klebsiella Pneumoniae Infection Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Klebsiella Pneumoniae Infection Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Klebsiella Pneumoniae Infection Drug. Industry analysis & Market Report on Klebsiella Pneumoniae Infection Drug is a syndicated market report, published as Global (United States, European Union and China) Klebsiella Pneumoniae Infection Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Klebsiella Pneumoniae Infection Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
